Trial intelligence / Profile preview

RENAAL: Losartan in Type 2 Diabetes with Nephropathy

NCT00308347Phase 3Completed

Sponsor
Organon & Co.
Start
May 1996
Primary completion
Feb 2001
Modality
Small Molecules
01

Overview

A Phase 3 trial of losartan in diabetic nephropathy (DN), sponsored by Organon & Co.. Started May 1996; status: completed.

02

Drugs

losartan
03

Conditions

diabetic nephropathy (DN)

Beyond the preview

Go deeper on NCT00308347.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00308347.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call